Gofen & Glossberg LLC IL raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,419 shares of the healthcare conglomerate’s stock after purchasing an additional 1 shares during the period. Gofen & Glossberg LLC IL’s holdings in UnitedHealth Group were worth $1,005,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of UNH. Harbour Capital Advisors LLC boosted its stake in UnitedHealth Group by 18,383.4% during the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after purchasing an additional 2,503,090 shares during the last quarter. Janus Henderson Group PLC boosted its stake in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock worth $442,896,000 after buying an additional 2,264,242 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after buying an additional 1,588,516 shares during the last quarter. Parametric Portfolio Associates LLC boosted its stake in shares of UnitedHealth Group by 77.3% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock worth $664,570,000 after buying an additional 1,562,661 shares during the last quarter. Finally, Jennison Associates LLC boosted its stake in shares of UnitedHealth Group by 180.4% in the 2nd quarter. Jennison Associates LLC now owns 2,252,507 shares of the healthcare conglomerate’s stock worth $417,660,000 after buying an additional 1,449,130 shares during the last quarter. Institutional investors and hedge funds own 86.20% of the company’s stock.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total value of $200,333.25. Following the sale, the insider now directly owns 24,630 shares in the company, valued at $5,060,726.10. The disclosure for this sale can be found here. Over the last three months, insiders have sold 62,606 shares of company stock worth $12,677,525. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Incorporated (NYSE UNH) traded up $2.39 during trading hours on Wednesday, reaching $224.88. The company’s stock had a trading volume of 1,345,627 shares, compared to its average volume of 3,100,740. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $215,879.17, a PE ratio of 23.20, a PEG ratio of 1.65 and a beta of 0.66. UnitedHealth Group Incorporated has a twelve month low of $156.09 and a twelve month high of $231.77.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period last year, the firm earned $2.17 earnings per share. research analysts forecast that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.33%. UnitedHealth Group’s dividend payout ratio is presently 33.26%.

A number of equities analysts have recently issued reports on UNH shares. UBS restated an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, August 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their price target on UnitedHealth Group from $215.00 to $235.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 18th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 5th. Finally, Leerink Swann reiterated a “buy” rating and set a $240.00 target price (up from $225.00) on shares of UnitedHealth Group in a research report on Wednesday, October 18th. Three investment analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $224.56.

ILLEGAL ACTIVITY WARNING: “UnitedHealth Group Incorporated (UNH) Holdings Increased by Gofen & Glossberg LLC IL” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/12/13/unitedhealth-group-incorporated-unh-holdings-increased-by-gofen-glossberg-llc-il.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related stocks with our FREE daily email newsletter.